NorthWest Biotherapeutics Inc (NWBO)

[ae kusterer]

martyDg: Let's fast forward to '29. Sawston free cash flow that year will be $1 billion. And the $ 1 billion cash received in late '24 in lawsuit settlements will still be on the balance sheet. What's the value of that to the 15 CI manufacturers?

Re: just Scottie post# 707760

Tuesday, July 23, 2024 5:11:04 PM

Post#
707820
of 707820
$0.20 is very possible; it’s a make-or-break at this point. The only near-future catalyst is approval, so if it’s disapproved, welcome to the pink sheets, possibly $0.001. If approved, then $1+. Then, move on to the next milestone, which is FDA approval, but without revenue, this won’t crawl up to $3-6.